← All trials
NCT04613960
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2020
- Primary completion
- May 31, 2022
- Completion date
- Aug 31, 2022
- First posted
- Nov 3, 2020
- Last posted
- Nov 6, 2020
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- General Committee of Teaching Hospitals and Institutes, EgyptLead sponsor
- General Committee of Teaching Hospitals and Institutes, EgyptReponsible party - principal investigator
- Ain Shams UniversityCollaborator
- Health Insurance Organization, EgyptCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.